RespirAq Humidifier Usability During Invasive Ventilation

NCT ID: NCT04765878

Last Updated: 2021-03-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-31

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to capture preliminary safety and effectiveness information on a near-final humidifier device design and to provide data for more extensive research, if required. This feasibility study will investigate the following: process, resources, management, and scientific aspects of delivering humidification by the RespirAq humidifier device in ventilated patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mechanical Ventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Humidification

Group Type EXPERIMENTAL

RespirAq Humidification

Intervention Type DEVICE

Humidifier

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RespirAq Humidification

Humidifier

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients scheduled for coronary artery bypass surgery (CABG) will be recruited before their surgical procedure at the Waikato district health board during February, March, and April of 2021.

Exclusion Criteria

* Age \<18 years
* Have any other condition which, at the investigator's discretion, is believed may present a safety risk or impact the feasibility of the study or the study results
* Patients admitted for emergency CABG surgery
* Unable to provide written informed consent before surgery
* Patients who would be contra-indicated to HME humidification devices
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Business, Innovation and Employment

UNKNOWN

Sponsor Role collaborator

Waikato District Health Board

UNKNOWN

Sponsor Role collaborator

Auckland University of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Melanie Moylan

Role: PRINCIPAL_INVESTIGATOR

Auckland University of Technology

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Catherine Redmond

Role: CONTACT

+649 921 9999 ext. 9386

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.